Riskpilot← Back to searchSign inGet full accessFakhro Medical AB
ABActiveOrg 5592202153Stora Trädgårdsgatan 8 Lgh 1402General medical practice activities · NACE 8621Est. 20192 employees
Revenue 2025
SEK 454K
-44% vs 2024
EBITDA margin
-9.7%
-119% vs 2024
Equity ratio
84.7%
Financial strength
Net profit 2025
SEK 0
-100% vs 2024
| Revenue | SEK 454K | -44% |
| EBITDA | SEK -44K | -119% |
| Net profit | SEK 0 | -100% |
| Total assets | SEK 575K | -29% |
| Equity | SEK 487K | -9% |
| Employees | 2 | — |
Legal name
Fakhro Medical AB
Org number
5592202153
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
27 september 2019
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolagets verksamhet ska vara konsultverksamhet inom hälso- och sjukvård, läkaruthyrning och uthyrning av annan personal inom sjukvård. Aktiebolaget ska på sjukhus, primärvård och andra vårdinrättningar erbjuda läkarbemanning. Det ska även vara tillgängligt för läkarbevakning under sport- och indrottsevenemang, samt friskvård, konsultativa uppdrag och pedagogiska uppgifter.
Address
Stora Trädgårdsgatan 8 Lgh 1402
Email
mohammedfakhro93@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 233 | 944 | 809 | 454 |
| Staff expenses | — | −6 | −119 | −196 | — |
| EBITDA | −33 | 126 | 433 | 236 | −44 |
| Depreciation & amort. | −0 | — | — | — | −0 |
| EBIT | −33 | 126 | 433 | 236 | −44 |
| Net financials | — | 0 | −163 | 1 | −7 |
| Profit before tax | −33 | 126 | 270 | 237 | 2 |
| Tax | −0 | −19 | −57 | −51 | −2 |
| Net profit | −33 | 107 | 213 | 186 | 0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 219 | 205 | 611 | 807 | 575 |
| Equity | 27 | 134 | 348 | 534 | 487 |
| Long-term debt | 0 | — | — | — | 0 |
| Short-term debt | 192 | 71 | 264 | 273 | 81 |
| Total debt | 192 | 71 | 264 | 273 | 81 |
EBITDA margin
-9.7%
This company
15.8%
Market median
-161% vs market
20212025
Equity ratio
84.7%
This company
38.2%
Market median
+122% vs market
20212025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
0.79×
This company
1.12×
Market median
-29% vs market
20212025
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MN Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2026 | |
| Deputy Board Member | 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Fakhro Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mohammed Nazem Fakhro | Chief Executive Officer | 0 companies |
| Ali Fakhro | Deputy Board Member | 0 companies |
| Ebtehaj Khalouf | Deputy Board Member | 0 companies |
| Saleh Ali Fakhro | Deputy Board Member | 0 companies |